Fallows Macaluso
Business & Development
Biotools Inc
Denmark
Biography
Ms. Jill Fallows Macaluso has been Vice President and Chief Compliance Officer at Novo Nordisk, Inc. since July 10, 2017. As Chief Compliance Officer and Vice President for Novo Nordisk Inc., Ms. Macaluso is charged with developing, operating and overseeing an effective healthcare compliance program within the United States. Utilizing 15 years of industry experience, Ms. Fallows Macaluso has been instrumental in driving the evolution of Novo Nordisk’s compliance program to support industry leading business practices. By serving as a corporate compliance partner, she has spearheaded efforts focused on rebranding and operational efficiency, as well as, strengthening global partnerships. Ms. Macaluso began assuming leadership responsibilities when she joined the Compliance Department as Senior Director in 2012. Prior to joining the Compliance Department, she served as Senior Corporate Counsel at the Novo Nordisk Inc. Legal Department for nine years where she held several key positions.
Research Interest
Ms. Macaluso was with the General Corporate and Healthcare practice of Day Pitney, LLP. She holds a Bachelor of Science in Nursing from the University of Pennsylvania and a Juries Doctorate from Rutgers University School of Law.
